DDS vs. NVO
Compare and contrast key facts about Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DDS or NVO.
Correlation
The correlation between DDS and NVO is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DDS vs. NVO - Performance Comparison
Key characteristics
DDS:
-0.51
NVO:
-1.27
DDS:
-0.50
NVO:
-1.91
DDS:
0.94
NVO:
0.75
DDS:
-0.57
NVO:
-0.88
DDS:
-1.37
NVO:
-1.87
DDS:
15.75%
NVO:
26.63%
DDS:
42.09%
NVO:
39.32%
DDS:
-93.94%
NVO:
-71.29%
DDS:
-37.60%
NVO:
-56.57%
Fundamentals
DDS:
$5.10B
NVO:
$296.36B
DDS:
$36.80
NVO:
$3.27
DDS:
8.71
NVO:
20.52
DDS:
-1.28
NVO:
1.04
DDS:
$6.57B
NVO:
$225.05B
DDS:
$3.83B
NVO:
$190.45B
DDS:
$948.26M
NVO:
$113.24B
Returns By Period
The year-to-date returns for both investments are quite close, with DDS having a -26.47% return and NVO slightly higher at -26.11%. Over the past 10 years, DDS has outperformed NVO with an annualized return of 11.51%, while NVO has yielded a comparatively lower 10.75% annualized return.
DDS
-26.47%
-12.24%
-8.34%
-19.15%
75.68%
11.51%
NVO
-26.11%
-30.05%
-44.79%
-48.54%
17.85%
10.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DDS vs. NVO — Risk-Adjusted Performance Rank
DDS
NVO
DDS vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DDS vs. NVO - Dividend Comparison
DDS's dividend yield for the trailing twelve months is around 8.20%, more than NVO's 2.58% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DDS Dillard's, Inc. | 8.20% | 6.02% | 5.18% | 4.89% | 6.41% | 0.95% | 0.68% | 0.66% | 0.57% | 0.45% | 0.40% | 0.19% |
NVO Novo Nordisk A/S | 2.58% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
DDS vs. NVO - Drawdown Comparison
The maximum DDS drawdown since its inception was -93.94%, which is greater than NVO's maximum drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for DDS and NVO. For additional features, visit the drawdowns tool.
Volatility
DDS vs. NVO - Volatility Comparison
Dillard's, Inc. (DDS) has a higher volatility of 15.86% compared to Novo Nordisk A/S (NVO) at 13.88%. This indicates that DDS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DDS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Dillard's, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities